Tivic Health Systems, Inc. is a biotechnology company developing immunotherapeutic approaches to modulating immune responses. In the past year, the company has shifted its focus to drug development ...
The company’s portfolio includes two programs: OKI-345 for breast cancer and OKI-355 for vascular anomalies. OnKure plans to submit Investigational New Drug applications to the U.S. Food and Drug ...
There is an increased international, national and statewide interest in advanced manufacturing—from new methods in additive manufacturing to co-robotics and digital manufacturing. An Advanced ...
Additional funding of €4m from new co-lead investor Biovance Capital, and €1.5m from existing co-lead Kurma Partners, to reach a total of €5.5m. Funds will be used to further develop Laigo’s SureTACs™ ...
A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...
April is National Reentry Awareness Month, and Goodwill is bringing resources, employers, and opportunities together in one place. Goodwill of North Georgia is hosting a job fair on April 9 from 11 ...
Eleven academic programs at the University of Wyoming will be eliminated, the board of trustees decided Wednesday. Two programs that were previously proposed for elimination will not be among them, ...
Acumen Pharmaceuticals Inc. has announced a $35.75 million private placement to advance molecules from its amyloid-β oligomer-selective Enhanced Brain Delivery (EBD) portfolio for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results